Biomedical subjects

Lars J Vatten

Publications and source records attributed to Lars J Vatten.

25 records · Page 2Linked to original sources

PubMed2003

Birth size in relation to age at menarche and adolescent body size: implications for breast cancer risk.

Early age at menarche and tallness are associated with increased risk for breast cancer, and emerging evidence suggests that body size at birth also is positively associated with breast cancer risk in adulthood. We have explored whether this effect of birth size could be mediated by influencing age at menarche or body height during adolescence. Information on age at menarche and adolescent height among 3,343 Norwegian girls 13 to 19 years of age, born at term and whose mothers had no history of gestational disease was individually linked to information on birth weight and length recorded in the national Medical Birth Registry. We related quintiles of birth size, adjusted for length of gestation, to age at menarche and adolescent height and weight, using general linear modeling and Cox regression analyses. In a subsample of the population, we also had information on maternal age at menarche, as well as adult height and body mass index in both parents. We explored whether parental factors confounded the association between perinatal predictors and adolescent outcomes in the daughters. We found that age at menarche tended to occur earlier with decreasing birth weight (p for trend = 0.03), and girls who were thin at birth (i.e., in the lowest quintile of ponderal index) had an earlier age at menarche than other girls (p = 0.02). Weight and length at birth were strongly and positively related to tallness during adolescence (p for trend < 0.001), but ponderal index, indicating obesity at birth, was negatively associated with adolescent height (p for trend = 0.002). Adjustment for parental height, body mass index and maternal age at menarche, in the subsample where this information was available, indicated no substantial confounding by these parental factors. Our results suggest that a positive association between birth size and adult breast cancer is not likely to be mediated by early age at menarche, but possibly by increased body height in adolescence.

Adolescent↗

PubMed2003

Intrauterine exposure to preeclampsia and adolescent blood pressure, body size, and age at menarche in female offspring.

OBJECTIVE: To investigate whether female offspring of preeclamptic pregnancies have higher blood pressure, lower height, higher body mass index (BMI), and later age at menarche compared with offspring of normotensive pregnancies. METHODS: Questionnaire information on age at menarche and measurements of blood pressure, height, and weight were collected among 4096 Norwegian girls 13-19 years old. Individual linkage to perinatal data registered at the national Medical Birth Registry allowed us to study the relationship of preeclampsia in the mother with adolescent blood pressure, body size, and age at menarche of daughters. RESULTS: Maternal preeclampsia was associated in the female offspring with higher systolic (2.9 mm Hg difference, P <.001) and diastolic (1.7 mm Hg difference, P =.001) blood pressure during adolescence and higher weight (3.4 kg difference, P <.001) and BMI (22.6 versus 21.5, P <.001). After adjustment for adolescent BMI, the difference in systolic blood pressure was attenuated from 2.9 to 1.7 mm Hg (P =.017), and from 1.7 to 0.9 mm Hg (P =.08) for diastolic blood pressure. CONCLUSION: Intrauterine exposure to preeclampsia was associated with increased adolescent blood pressure. The association may be causally related to adult hypertension but could also be confounded by higher BMI during adolescence.

Adolescent↗

PubMed2003

Pregnancy hormones, pre-eclampsia, and implications for breast cancer risk in the offspring.

The aim of this study is to prospectively assess pregnancy hormone levels as correlates of subsequent development of pre-eclampsia, a condition that has been shown to be inversely associated with breast cancer risk in the offspring. A cohort of 260 Caucasian women in Boston, Massachusetts, was followed through pregnancy. Maternal blood was collected at the 16th and 27th weeks of gestation, and 18 women were diagnosed with pre-eclampsia after blood collection. Information on sociodemographic variables and risk factors of pre-eclampsia was collected through an interviewer-administered questionnaire and review of medical records. At the 16th week, there was a nonsignificant positive association between progesterone levels and pre-eclampsia [relative risk (RR) = 1.63, 95% confidence interval (CI), 0.97-2.74, per 1 SD increase]. By the 27th week, the association between progesterone and pre-eclampsia was strengthened (RR = 2.65, 95% CI, 1.46-4.81, per SD), and sex hormone-binding globulin levels were somewhat inversely related to pre-eclampsia (RR = 0.61, 95% CI, 0.31-1.20, per SD). No difference was found with respect to prolactin, estradiol, and estriol levels. Our findings indicate that progesterone may have a role in the late manifestation of pre-eclampsia pathology but are also compatible with the hypothesis that increases in progesterone represent an early compensatory mechanism.

Adult↗

PubMed2002

[Fetal growth, pre-eclampsia and adult breast cancer risk].

BACKGROUND: Studies of the association between birth weight and future breast cancer risk have shown inconsistent results, but women born after preeclamptic pregnancies may have a risk reduction of more than 50% compared to other women. In this review we have examined the literature on the association between perinatal factors and adult risk of breast cancer. MATERIAL AND METHODS: We searched Medline for published literature until February 1, 2002 and included references that were not available through Medline, but have been referenced in other articles. RESULTS: Papers published until the beginning of 2002 suggest that birth weight is positively, but not strongly, associated with future risk of breast cancer. On the other hand, women who were exposed to preeclampsia in utero have a striking reduction in breast cancer risk compared to women whose mothers had uncomplicated pregnancies. Besides, dizygotic twins appear to be at increased risk, whereas monozygotic twins may have a reduced risk of breast cancer, compared to the general population. INTERPRETATION: The literature published until the beginning of 2002 suggests that factors that operate in utero are associated with future risk of breast cancer. Factors that increase growth velocity may be related to increased risk, whereas factors with anti-oestrogenic properties may have a protective effect.

Adult↗

PubMed2002

Relationship of insulin-like growth factor-I and insulin-like growth factor binding proteins in umbilical cord plasma to preeclampsia and infant birth weight.

OBJECTIVE: To determine whether preeclampsia influences insulin-like growth factor-I (IGF-I), insulin-like growth factor binding protein-1 (IGFBP-1), and insulin-like growth factor binding protein-3 (IGFBP-3), independent of its effect on birth weight. METHODS: Cord blood was collected in 12,804 consecutive deliveries. We identified 258 preeclamptic pregnancies that were subclassified as mild or severe and early or late. For comparison, 609 control pregnancies were selected. Fetal growth was expressed as the ratio between observed and expected birth weight, with adjustment for gestational age at birth. IGF-I, IGFBP-1, and IGFBP-3 were measured in umbilical plasma. The contribution of preeclampsia and birth weight to each measured factor was assessed by multiple linear regression analyses. RESULTS: Between mild preeclampsia and controls, there were no differences in IGF-I, IGFBP-1, and IGFBP-3. In severe and early onset preeclampsia, umbilical cord plasma IGF-I was approximately 50% lower, and IGFBP-1 was more than twice as high as in controls (both P <.01). At each birth weight level, IGF-I was lower and IGFBP-1 was higher in severe or early preeclampsia than among controls of similar weight. Birth weight and preeclampsia were, independent of each other, associated with IGF-I, whereas birth weight, but not preeclampsia, was associated with IGFBP-1, after adjustment for gestational age. CONCLUSION: Fetal growth restriction caused by severe or early preeclampsia is associated with lower umbilical levels of IGF-I than low birth weight caused by other conditions. Preeclampsia may contribute to the observed IGF-I reduction, either as part of the underlying causes of preeclampsia, or as a consequence of the disease.

Adult↗

PubMed2002

Umbilical cord plasma leptin is increased in preeclampsia.

OBJECTIVE: The objective of this study was to compare umbilical cord plasma leptin between infants of mothers who experienced preeclampsia and infants of control subjects and to study the relation between cord plasma leptin and infant obesity, as indicated by ponderal index. STUDY DESIGN: On the basis of a population of approximately 13,000 deliveries, we compared cord plasma leptin from preeclamptic (n = 256 women) and control pregnancies (n = 607 women) after taking the differences in gestational age and ponderal index into account. RESULTS: Cord plasma leptin increased strongly with gestational age, both in the preeclampsia group and the control subjects (P <.01), but at each gestational age the preeclampsia group had higher leptin levels than control subjects (P <.01). Adjustment for the higher ponderal index among control subjects (P <.05) did not alter the difference in leptin levels between the groups. CONCLUSION: We found higher levels of umbilical cord plasma leptin in infants of mothers who had preeclampsia (compared with infants of control subjects) after adjusting for differences in gestational age, gender, and infant ponderal index.

Adult↗

PubMed2002

Insulin-like growth factor I and leptin in umbilical cord plasma and infant birth size at term.

OBJECTIVE: To determine the independent contributions to infant birth size of insulin-like growth factor I (IGF-I) and leptin measured in umbilical cord plasma. METHODS: Umbilical cord blood was collected in 12 804 consecutive deliveries, and cord plasma from 585 singleton infants born at term after uncomplicated pregnancies was analyzed for leptin, IGF-I, and 2 IGF-binding proteins (IGFBP-1 and IGFBP-3). In multivariable analyses, we assessed maternal and infant covariates of leptin and IGF-I, and we evaluated the independent contribution of cord levels of leptin and IGF-I on infant birth size. RESULTS: Cord plasma levels of IGF-I were lower in women who reported smoking at the beginning of pregnancy compared with nonsmokers. In female infants, levels of IGF-I and leptin were higher than in male infants after adjustment for ponderal index and maternal factors. We found a strong parallel increase in umbilical IGF-I and leptin with increasing birth weight and birth length. For IGFBP-1, there was an opposite pattern: IGFBP-1 increased with decreasing birth size. The multivariable analysis, adjusted for length of gestation and maternal age, parity, prepregnancy weight, smoking during pregnancy, and offspring sex, showed that IGF-I and leptin, independent of each other, were associated with birth weight and birth length. CONCLUSIONS: Levels of IGF-I and leptin in umbilical cord plasma were higher in girls than in boys, but in both sexes, these 2 factors contributed independently and positively to birth weight and length. For IGFBP-1, high levels were associated with low birth weight and reduced length. If intrauterine growth is related to the risk of developing adult diseases, IGF-I, IGFBP-1, and leptin may be involved in the underlying processes.1131-1135 insulin like growth factors, leptin, umbilical cord plasma, birth weight.

Birth Weight↗